CLINICAL ROLE -
Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis
Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Read More